Business Description
BetterLife Pharma Inc
NAICS : 325411
SIC : 3741
ISIN : CA72580T2020
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | -13.63 | |||||
Debt-to-Equity | -0.22 | |||||
Debt-to-EBITDA | -0.62 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 73.1 | |||||
3-Year EPS without NRI Growth Rate | 51.6 | |||||
3-Year FCF Growth Rate | 55.9 | |||||
3-Year Book Growth Rate | -1.1 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.36 | |||||
9-Day RSI | 41.27 | |||||
14-Day RSI | 44.3 | |||||
6-1 Month Momentum % | 43.24 | |||||
12-1 Month Momentum % | 44.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.12 | |||||
Quick Ratio | 0.12 | |||||
Cash Ratio | 0.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.1 | |||||
Shareholder Yield % | -3.89 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -811.64 | |||||
ROIC % | -793.9 | |||||
3-Year ROIIC % | -2910.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -4.53 | |||||
EV-to-EBITDA | -4.53 | |||||
EV-to-FCF | -10.5 | |||||
Earnings Yield (Greenblatt) % | -22.03 | |||||
FCF Yield % | -10.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BetterLife Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.026 | ||
Beta | 1.42 | ||
Volatility % | 71.57 | ||
14-Day RSI | 44.3 | ||
14-Day ATR (€) | 0.008883 | ||
20-Day SMA (€) | 0.0807 | ||
12-1 Month Momentum % | 44.55 | ||
52-Week Range (€) | 0.024 - 0.138 | ||
Shares Outstanding (Mil) | 129.46 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BetterLife Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BetterLife Pharma Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
BetterLife Pharma Inc Frequently Asked Questions
What is BetterLife Pharma Inc(FRA:NPAU)'s stock price today?
When is next earnings date of BetterLife Pharma Inc(FRA:NPAU)?
Does BetterLife Pharma Inc(FRA:NPAU) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |